Antibodies: Treatment, prevention, and cure?

We’ve reported extensively on antibodies over the past few years as they have come to revolutionize efforts to prevent or treat HIV infection. Progress on this front continues. In this issue we report on the major findings presented at the HIV Research for Prevention (HIVR4P) conference held in October. At this meeting, as in many of recent memory, antibodies were a prominent theme. From the trials testing the ability of directly administered broadly neutralizing antibodies to prevent HIV infection to the latest efforts to engineer a series of vaccine immunogens that could induce these powerful proteins, antibodies are fueling scientific developments in many areas.


Recent Features

Living Positive in Malaysia

HIV GreenQ&A with Andrew Tan, founder and president of myPlus, a network of HIV-positive people in Malaysia. Tan came out in public as an HIV-positive gay man in his speech opening night of IAS 2013.


Clinical Trials Database



An interactive search of trials and results


Upcoming Meetings

Saturday, February 11 2017
7th International Workshop on HIV & Women
Seattle, Washington, USA
Monday, February 13 2017
Conference on Retroviruses and Opportunistic Infections

Sunday, March 26 2017
Keystone Symposia: HIV Vaccines
Steamboat Springs, Colorado, USA